Researchers are exploring various approaches to target tumor dormancy in breast cancer therapeutics, examining the hallmarks and mechanisms of the disease. Studies are investigating the biological mechanisms of cancer metastasis, the role of the tumor microenvironment, and potential therapeutic strategies, including peptide delivery and targeted therapies. The goal of this research appears to be preventing breast cancer recurrence by understanding and addressing the complex processes involved in tumor dormancy and metastasis.